DIABETES MELLITUS TYPE 2

This study tested the drug empagliflozin in 20 kidney transplant recipients, some with type 2 diabetes and some without. The goal was to see if the drug could improve kidney function, heart structure, and blood sugar levels. Participants took either empagliflozin or a placebo for…

This study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity achieve remission or significant weight loss. Researchers tracked gut microbiome changes and health indicators over two years. The study was termi…

This study aimed to see if following the dosing instructions for oral semaglutide helps improve blood sugar control in people with type 2 diabetes who are already taking metformin. Only one person enrolled before the study was stopped early. The main focus was on changes in time …

This early-stage study tested a new drug called AP026 in healthy adults to see if it is safe and tolerable. The trial was stopped early and only enrolled 14 people instead of the planned 74. Researchers were looking for side effects and how the drug moves through the body, but no…

This study aimed to see if it's possible for hospitalized patients with type 2 diabetes to do daily resistance training. Researchers planned to enroll 24 patients but stopped early after only 4 joined. The goal was to gather information on how to run such a study, not to prove ex…

This study aimed to understand how dapagliflozin, a diabetes medication, might improve blood vessel health in people with type 2 diabetes. Researchers planned to measure changes in blood pressure and other vascular markers in a small group of participants. The study was terminate…

This study aimed to see if a urine test can accurately detect when people with type 2 diabetes are not taking their medications as prescribed. Researchers planned to compare the urine test results with standard methods like questionnaires and pharmacy refill records in 600 adults…